ArticleNPJ breast cancer2026

Molecular profile of residual triple-negative breast cancer: opportunities for post-neoadjuvant therapeutic interventions.

Nadine S van den Ende et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.